Carronade Capital Management, LP (together with its affiliates,
“Carronade Capital”, “our” or “we”), which beneficially owns
approximately 2.9 million shares of Common Stock of Cannae
Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) and is one
of the Company’s top five shareholders, today announced it has
issued the below letter to Cannae’s Board of Directors (the
“Board”) and nominated four independent director candidates for the
four Board seats up for election at the Company’s 2025 Annual
Meeting of Shareholders.
Carronade Capital believes Cannae’s total shareholder return and
corporate governance can be meaningfully improved, and significant
opportunities exist to unlock substantial value for all
shareholders. We believe Cannae can halt persistent
underperformance and restore shareholder confidence by improving
capital allocation and unlocking portfolio value through spin outs
or buybacks, reducing overhead costs and aligning management
incentives, and establishing corporate governance and
accountability. If decisive action is taken, we believe that Cannae
equity could have a share price upside of at least 50% as a result
of activities initiated by year end.
Carronade’s four highly qualified nominees are as follows:
Mona Aboelnaga
- 35 years of experience including at Siguler Guff & Company
and Proctor Investment Managers with expertise in investment
management and private equity industries.
- Extensive corporate governance expertise as a board member of
both public and private companies including Webster Financial, a
financial services company, Perpetual Limited, an Australian-based
diversified global financial services company, and Sterling
Bancorp, a regional financial services company.
Benjamin Duster
- 45 years of experience including at Wells Fargo and Salomon
Brothers with expertise in working with companies to improve
execution effectiveness and create long-term sustainable
value.
- Extensive public and private company board service including
Expand Energy, an oil and gas production company, Weatherford
International, a global energy services company, Republic First
Bancorp, a commercial bank, and Alaska Communications Systems, a
broadband and telecommunications service provider.
Dennis Prieto
- 21 years of experience including at Aurelius Capital Management
and Evercore with expertise in financial analysis and restructuring
oversight.
- Significant investment management and board experience
including GO Lab, a privately held building products company,
Aventiv Technologies, a provider of telecommunications and
technology solutions, Mohawk Gaming Enterprises, a gaming company,
and Endo International GUC Trust, a trust established to obtain
recoveries for creditors of Endo International plc.
Cherie Schaible
- 24 years of experience including as General Counsel of Ankura
Consulting Group and Associate General Counsel of AIG Investments
with expertise in complex legal and financial matters.
- Extensive experience in structuring, negotiating and leading a
variety of corporate legal matters in public and private
companies.
The full text of the letter is below:
March 20, 2025
Cannae Holdings, Inc.1701 Village Center CircleLas Vegas, Nevada
89134Attn: Board of Directors
Dear Members of the Board of Directors,
Entities managed by Carronade Capital Management, LP (together
with its affiliates, “Carronade Capital” or “We” or “Us” or “Our”)
beneficially own approximately 2.9 million shares of Common Stock
of Cannae Holdings, Inc. (“Cannae” or the “Company” or “You” or
“Your”), making us one of your top five investors. We believe
Cannae’s total shareholder return (“TSR”) and corporate governance
can be meaningfully improved, and significant opportunities exist
within the control of both management and the Board of Directors
(the “Board”) to unlock substantial value for all shareholders. We
are reiterating these previously communicated views to you, and the
broader market, to ensure the entire Board is made aware of our
discussions to date and to highlight this potential value creation
opportunity in the hope of building a consensus for the best path
forward.
Our letter today outlines why we believe the status quo at
Cannae is untenable and why dramatic change is required to halt
persistent underperformance and egregious governance practices for
the benefit of all stakeholders. We believe there are numerous ways
to drive value creation, and, by extension, shareholder returns,
including by reducing costs and aligning incentives, improving
capital allocation, unlocking the value of the parts of the
portfolio, and establishing corporate governance and accountability
by reconstituting the Board with truly independent directors.
If Cannae takes decisive action to properly implement these
achievable steps and rebuild investor confidence, we believe that
the equity could have share price upside of at least 50% as a
result of activities initiated by year-end.
The Status Quo is Untenable
In our view, there is an urgent need for changes in strategy and
governance based on Cannae’s substantial long-term relative TSR
underperformance, persistent discount to intrinsic value,
shareholder frustration with corporate strategy, and a pattern of
governance deficiencies that we believe have significantly hindered
the Company’s ability to create shareholder value. Our concerns are
underscored by the high degree of interconnectedness amongst the
current directors and Cannae’s classified Board structure which,
among other governance concerns, have resulted in repeated adverse
voting recommendations from leading proxy advisory firms. We were
further shocked by the Board’s egregious actions earlier this week,
while we were engaged in active settlement discussions, to
accelerate equity vesting for directors if they fail to be
re-elected by shareholders and to require the repurchase of half of
CEO and Chairman Bill Foley’s shares at a significant premium to
market prices. This is on top of his already rich compensation
package if he invokes his right to resign because a single director
is elected without his consent. That a Board of Directors deemed
these actions consistent with their fiduciary duties and in the
best interest of shareholders demonstrates a complete lack of
independence and an abdication of their duty. We believe such an
offensive combination of entrenchment techniques and unfair
enrichment are beyond the pale and make it crystal clear that
immediate change is necessary in the boardroom.
Management’s stated strategy consists of “improving the
performance and valuation of our portfolio companies, making new
investments primarily in private companies that will grow NAV, and
returning capital to shareholders.”1 Put plainly, management’s plan
is not working. Cannae has a valuable collection of assets, but
buybacks to date have failed to close the discount due to market
concerns around overall strategy and perceived misalignment of
interests between management and shareholders. Shareholders have
consistently shared concerns that they do not want Cannae to sell
public shares to invest in small private positions with no
disclosure – such actions we believe would only compound the
current problems and Cannae’s persistent value discount. Despite a
handful of successful investments in the past, the current
portfolio of private investments is consistently marked at cost and
the remaining investments in public equities have destroyed
approximately $900 million of value.2 Market feedback that we have
gathered to date suggests a near unanimous view that numerous
shareholders prefer a return of their capital as opposed to
management’s stated goal of selling down public positions to invest
more in private equity.
“Since Ceridian, they have made a bunch of bad capital allocation
decisions…We would rather them distribute value than re-invest.
They haven’t earned the right to keep that capital.” |
– Top 10 Shareholder, Nov. 2024 |
|
Furthermore, a lack of strategic cohesion amongst investments
and limited portfolio company disclosure weigh on investor
confidence. There has been no clear investment narrative for
shareholders to rally behind, as we consistently hear Cannae
described simply as the Bill Foley co-investment vehicle.
Additionally, we believe the persistent marking of private
investments at cost without balance sheet information and absence
of third-party valuations, or enough disclosure for investors to
determine performance, are significant contributors to the wide NAV
discount. As one analyst queried on the Company’s third quarter
2024 earnings call:
“If you had your wish how many positions would you have? How large
would they be and I just think I kind of look at some of the parts…
It's just kind of all over the place you have things that are worth
less than $1 per share and I just don't see the focus here.” |
– Oppenheimer Q&A on Q3 2024 Earnings Call |
|
As a result of these perceptions in the market, Cannae trades at
a much steeper discount to NAV than its disclosed proxy peers and
closed end fund peers. The discount widened persistently after the
IPO of Dun & Bradstreet in 2019 and the sell down of Dayforce
from 2020 through 2023, implying the market lacks confidence in the
current leadership’s ability to execute a viable strategy for value
creation going forward. Over the past three years, Cannae equity
has traded at an average discount to its NAV per share of -40%,
which places it in the bottom tenth of US investment firms with
assets over $500 million.3 Approximately 90% of Cannae’s market cap
is covered by public holdings net of debt, and the market is
valuing the remaining nearly $900 million of private NAV at an 85%
discount. A well-managed company with a strong asset base should
not be trading at such a deep discount. We believe this
misalignment points to a failure in capital allocation, strategic
planning, and governance oversight.
Shareholders ‘vote with their feet’, and the most objective
indication that fundamental change is required is relative TSR
underperformance compared to peers over the long term. Even when
viewed on an absolute basis, Cannae shareholders have suffered a
negative total return since Cannae became an independent public
company despite the backdrop of one of the strongest bull markets
in history. Despite the readily identifiable value in the Company’s
portfolio, Cannae’s stock has significantly underperformed most
relevant benchmarks.4 Consistent underperformance is the
market telling Cannae, “The status quo is
unacceptable.”
Dramatic Change is Required Immediately
As discussed previously with Mr. Foley and Mr. Caswell, we
believe Cannae can resolve these issues through decisive action in
the near term. We believe that Cannae must pursue the following
initiatives without delay:
- Reduce overhead costs and align management
incentives – A history of burdensome fees and
non-performance linked compensation paid out to management are out
of step with the overall performance of Cannae’s portfolio, are
impacting the discount which the market places on the NAV, and need
to be streamlined to reflect best-in-class approach. We believe the
Company should implement a corporate overhead cost reduction
program and convert the termination fee payable to its manager,
Trasimene Capital Management, into performance-based, vesting stock
compensation.
- Improve capital allocation, unlock portfolio value, and
provide a clear investment narrative – Management’s
current strategy is vague and undifferentiated, and shareholder
feedback is that management has lost its mandate from shareholders
to allocate capital in this way. We believe a commitment from
management and the Board to return shareholder capital tied up in
Dun & Bradstreet, Alight and Paysafe shares either via spin
outs or substantial buybacks would force a collapse of the discount
placed on those assets and result in a re-rating of the remaining
portfolio. We appreciate that management has conceded in its last
earnings call that a significant return of capital is a priority;
however, we believe that Cannae should commit definitively to
returning a substantial majority of this capital on an accelerated
timeline. Management could then reallocate its time from monitoring
small stakes in large public companies where their ability to
“improve the performance and valuation” is limited to focusing on
improving disclosure and valuation of the remaining private
assets.
- Establish governance oversight – We believe
that market confidence in this new plan would be best supported by
new fit-for-purpose directors that will be a voice for shareholders
on the Board. To that end, we delivered a formal notice in December
nominating a slate of four highly qualified and independent
director candidates for election to the Board at the Company’s 2025
Annual Meeting of Stockholders (the “Annual Meeting”). In addition
to the four new directors, we believe the Board should refresh
leadership of the Affiliate Transaction Committee and the
Nomination and Governance Committee chosen from the four new
candidates, and the Board should also create a new committee for
Value Maximization tasked with the formulation and oversight of
successful execution of a plan designed to improve shareholder
returns. The need for immediate and significant governance reform
is underscored by Cannae’s entrenchment and unfair enrichment
actions earlier this week.
Our intent at the time of nomination was, and continues to be,
to engage constructively with the Board with the goal of reaching a
consensual solution for the benefit of all stakeholders. However,
it appears that the current Board fails to recognize the urgency of
the situation. We are therefore prepared to take all necessary
steps to ensure that shareholders have the opportunity to vote for
directors who they believe have the skill sets and experience
necessary to drive value creation and ensure accountability in the
boardroom.
Management’s Lack of Willingness to Meaningfully
Engage
We have sought to engage with management and the Board for
several months to convey our views with respect to corporate
strategy and governance with the aim of closing the NAV discount
and improving relative share price performance. As discussed in our
original private letter to the Board dated December 19, 2024, we
submitted our nomination notice as required under the Company’s
Bylaws despite the nomination deadline of December 27, 2024, nearly
six months ahead of the anticipated Annual Meeting date. We did so
in order to preserve our rights as shareholders to elect directors
at the Annual Meeting, but with the hope that it would serve as a
starting point for further positive discussions. Unfortunately, we
now believe our sincere efforts to engage constructively have not
been meaningfully reciprocated in good faith.
While the Company confirmed receipt of our December letter and
nomination notice, it was more than thirty days before we received
any further communication. Given the Company’s significant
governance failings and chronic underperformance, we have offered
to travel to meet in-person with relevant Board members, but Cannae
has yet to permit us to speak with any non-management directors.
Perhaps as a result, the Board has failed to appreciate the
market’s call for urgent, meaningful governance changes. Then on
March 17, 2025, we were astounded to learn via a Company 8-K that
the Board, in an apparent move to entrench and enrich leadership,
determined to further compensate themselves and Mr. Foley at the
expense of shareholders. We believe this offensive action trounces
shareholder rights and the Board’s fiduciary duties and further
disenfranchises the Company’s true owners. It also makes clear to
us that Cannae has not been engaging in good faith dialogue despite
our persistent and sincere efforts, which necessitated the need to
release this letter with the goal of reaching the entire Board and
building a market consensus on the best path forward for the
Company.
Carronade Has Nominated Four Highly Qualified Director
Candidates
The fundamental role of a Board in its fiduciary duty to
shareholders is to be an advocate in providing oversight of
management and corporate strategy. Shareholders deserve a board
that is proactive, transparent, and fully committed to driving
long-term value. As evidenced by their backgrounds below, we
believe our candidates will bring the expertise, independence and
accountability required to correct the chronic underperformance of
Cannae and champion its strategic transformation.
- Mona Aboelnaga
- 35 years of experience including at Siguler Guff & Company
and Proctor Investment Managers with expertise in investment
management and private equity industries.
- Extensive corporate governance expertise as a board member of
both public and private companies including Webster Financial, a
financial services company, Perpetual Limited, an Australian-based
diversified global financial services company, and Sterling
Bancorp, a regional financial services company.
- Benjamin Duster
- 45 years of experience including at Wells Fargo and Salomon
Brothers with expertise in working with companies to improve
execution effectiveness and create long-term sustainable
value.
- Extensive public and private company board service including
Expand Energy, an oil and gas production company, Weatherford
International, a global energy services company, Republic First
Bancorp, a commercial bank, and Alaska Communications Systems, a
broadband and telecommunications service provider.
- Dennis Prieto
- 21 years of experience including at Aurelius Capital Management
and Evercore with expertise in financial analysis and restructuring
oversight.
- Significant investment management and board experience
including GO Lab, a privately held building products company,
Aventiv Technologies, a provider of telecommunications and
technology solutions, Mohawk Gaming Enterprises, a gaming company,
and Endo International GUC Trust, a trust established to obtain
recoveries for creditors of Endo International plc.
- Cherie Schaible
- 24 years of experience including as General Counsel of Ankura
Consulting Group and Associate General Counsel of AIG Investments
with expertise in complex legal and financial matters.
- Extensive experience in structuring, negotiating and leading a
variety of corporate legal matters in public and private
companies.
Conclusion
We remain committed, engaged investors in Cannae due to our
conviction in the significant opportunity for value creation that
will flow from implementing achievable actions to unlock value,
outlining a clear corporate strategy, establishing governance and
restoring investor confidence. We repeat our request to meet
in-person with the Board, including non-management directors, to
discuss these proposals in more detail and explore a consensual
solution that is in the best interests of all shareholders. If
meaningful changes are not enacted, we are prepared to take our
case to shareholders so that they have the opportunity to vote for
directors who they believe will best prioritize their interests and
ensure accountability in the boardroom.
Sincerely,
Dan GropperManaging Partner
Andy TaylorPartner and Head of Research
About Carronade CapitalCarronade Capital is a
multi-strategy investment firm based in Connecticut with over $2.2
billion in assets under management that focuses on process driven
investments in catalyst-rich situations. Carronade Capital was
founded in 2019 by industry veteran Dan Gropper and is based in
Darien, Connecticut. The Funds managed by Carronade Capital were
launched on July 1, 2020, and the firm employs 15 team members. Dan
Gropper brings with him nearly three decades of special situations
credit experience serving in senior roles at distinguished
investment firms, including Elliott Management Corporation,
Fortress Investment Group and Aurelius Capital Management, LP.
Media Contact:Paul Caminiti / Jacqueline
ZuhseReevemark(212) 433-4600Carronade@reevemark.com
Investor Contact: Andy Taylor / Win Rollins
Carronade Capital Management, LP(203) 485-0880ir@carronade.com
Disclaimers
This press release does not constitute an offer to sell or a
solicitation of an offer to buy any of the securities described
herein in any state to any person. This press release does not
recommend the purchase or sale of a security. There is no assurance
or guarantee with respect to the prices at which any securities of
Cannae Holdings, Inc. (the "Company") will trade, and such
securities may not trade at prices that may be implied herein. In
addition, this press release and the discussions and opinions
herein are for general information only, and are not intended to
provide financial, legal or investment advice. Each shareholder of
the Company should independently evaluate the proxy materials and
make a decision that aligns with their own financial interests,
consulting with their own advisers, as necessary.
This press release contains forward-looking statements.
Forward-looking statements are statements that are not historical
facts and may include projections and estimates and their
underlying assumptions, statements regarding plans, objectives,
intentions and expectations with respect to future financial
results, events, operations, services, product development and
potential, and statements regarding future performance.
Forward-looking statements are generally identified by the words
"expects", "anticipates", "believes", "intends", "estimates",
"plans", "will be" and similar expressions. Although Carronade
Capital and its affiliates believe that the expectations reflected
in forward-looking statements contained herein are reasonable,
investors are cautioned that forward-looking information and
statements are subject to various risks and uncertainties—many of
which are difficult to predict and are generally beyond the control
of Carronade or the Company—that could cause actual results and
developments to differ materially from those expressed in, or
implied or projected by, the forward-looking information and
statements. In addition, the foregoing considerations and any other
publicly stated risks and uncertainties should be read in
conjunction with the risks and cautionary statements discussed or
identified in the Company's public filings with the U.S. Securities
and Exchange Commission, including those listed under "Risk
Factors" in the Company's annual reports on Form 10-K and quarterly
reports on Form 10-Q . The forward-looking statements speak only as
of the date hereof and, other than as required by applicable law,
Carronade does not undertake any obligation to update or revise any
forward-looking information or statements. Certain information
included in this press release is based on data obtained from
sources considered to be reliable. Any analyses provided herein is
intended to assist the reader in evaluating the matters described
herein and may be based on subjective assessments and assumptions
and may use one among alternative methodologies that produce
different results. Accordingly, any analyses should not be viewed
as factual and should not be relied upon as an accurate prediction
of future results. All figures are estimates and, unless required
by law, are subject to revision without notice.
Certain of the funds(s) and/or account(s) managed by Carronade
(“Accounts”) currently beneficially own shares of the Company.
Carronade in the business of trading (i.e., buying and selling)
securities and intends to continue trading in the securities of the
Company. You should assume the Accounts will from time to time sell
all or a portion of its holdings of the Company in open market
transactions or otherwise, buy additional shares (in open market or
privately negotiated transactions or otherwise), or trade in
options, puts, calls, swaps or other derivative instruments
relating to such shares. Consequently, Carronade's beneficial
ownership of shares of, and/or economic interest in, the Company
may vary over time depending on various factors, with or without
regard to Carronade's views of the Company's business, prospects,
or valuation (including the market price of the Company's shares),
including, without limitation, other investment opportunities
available to Carronade, concentration of positions in the
portfolios managed by Carronade, conditions in the securities
markets, and general economic and industry conditions. Without
limiting the generality of the foregoing, in the event of a change
in the Company's share price on or following the date hereof,
Carronade may buy additional shares or sell all or a portion of its
Account’s holdings of the Company (including, in each case, by
trading in options, puts, calls, swaps, or other derivative
instruments relating to the Company’s shares). Carronade also
reserves the right to change the opinions expressed herein and its
intentions with respect to its investment in the Company, and to
take any actions with respect to its investment in the Company as
it may deem appropriate, and disclaims any obligation to notify the
market or any other party of any such changes or actions, except as
required by law.
Certain Information Concerning the
Participants
Carronade Capital Management, LP, together with
the other participants named herein (collectively, "Carronade
Capital"), intends to file a preliminary proxy statement and
accompanying proxy card with the Securities and Exchange Commission
("SEC") to be used to solicit votes for the election of Carronade
Capital’s highly-qualified director nominees at the 2025 annual
meeting of stockholders of Cannae Holdings, Inc., a Nevada
corporation (the “Company”).
CARRONADE CAPITAL STRONGLY ADVISES ALL
STOCKHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER
PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN
IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO
CHARGE ON THE SEC’S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION,
THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF
THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST.
REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS’ PROXY
SOLICITOR.
The participants in the proxy solicitation are
anticipated to be Carronade Capital Master, LP (“Carronade”),
Carronade Capital, Carronade Capital GP, LLC (“Carronade GP”),
Carronade Capital Management GP, LLC (“Carronade Management GP”),
Dan Gropper, Mona Aboelnaga, Benjamin C. Duster, IV, Dennis A.
Prieto and Chérie L. Schaible.
As of the date hereof, Carronade beneficially
owns directly 2,627,877 shares of Common Stock, par value $0.0001
per share, of the Company (the “Common Stock”). Carronade GP, as
the general partner of Carronade, may be deemed the beneficial
owner of the 2,627,877 shares of Common Stock owned by Carronade.
As of the date hereof, 262,770 shares of Common Stock were held in
a certain account managed by Carronade Capital (the “Managed
Account”). Carronade Capital, as the investment manager of
Carronade, may be deemed the beneficial owner of an aggregate of
2,890,647 shares of Common Stock directly owned by Carronade and
held in the Managed Account. Carronade Management GP, as the
general partner of Carronade Capital, may be deemed the beneficial
owner of an aggregate of 2,890,647 shares of Common Stock directly
owned by Carronade and held in the Managed Account. As the Managing
Member of Carronade Management GP, Mr. Gropper may be deemed the
beneficial owner of an aggregate of 2,890,647 shares of Common
Stock directly owned by Carronade and held in the Managed Account.
As of the date hereof, Ms. Aboelnaga directly beneficially owns 800
shares of Common Stock. As of the date hereof, Mr. Duster directly
beneficially owns 1,338.329 shares of Common Stock. As of the date
hereof, Mr. Prieto directly beneficially owns 820 shares of Common
Stock. As of the date hereof, Ms. Schaible directly beneficially
owns 1,360 shares of Common Stock.
____________________________
Note: All analyses performed as of 3/17/2025.1 Ryan Caswell on
Q3 2024 Earnings Call.2 Current GAV plus realized sales compared to
original cost basis of DNB, ALIT, PSFE, and SST.3 Company published
NAV reports.4 TSR per Bloomberg as of 3/17/2025. Average cumulative
shareholder return. TSR Proxy Peers include APO, FSK, GBDC, PSEC,
CODI, NMFC. Closed End Fund Peers include UTG, STEW, KYN, CET, GAM,
IGR, EOI, MEGI, PEO.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/77496dfe-1ffc-44b7-94dd-bbd69816468b
Grafico Azioni Cannae (NYSE:CNNE)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Cannae (NYSE:CNNE)
Storico
Da Mar 2024 a Mar 2025